Transdermal patch for treating osteoarthritis
AssigneeHisamitsu Pharmaceutical Co., Inc.
InventorsHiroyuki SATO, Hirochika TAKANO
Life of this patent
Estimating the term…
Abstract
Disclosed is a transdermal patch for treating osteoarthritis. The transdermal patch comprises a support layer and an adhesive layer laminated on the support layer. The adhesive layer includes an adhesive base, diclofenac sodium, dimethyl sulfoxide, and an organic acid. The organic acid content is 6-8 mass % of the total mass of the adhesive layer. The transdermal patch is applied once daily to an affected part and the dosage of diclofenac sodium per application is 70-150 mg.
Claims21
1-24. (canceled)
A patch for treating osteoarthritis, comprising a backing layer and an adhesive layer laminated on the backing layer,
- wherein the adhesive layer comprises an adhesive base, diclofenac sodium, dimethyl sulfoxide, and an organic acid,
- wherein a content of the organic acid is 6 mass % to 8 mass % with respect to a total mass of the adhesive layer, and
- wherein the patch is used to be applied to an affected part once a day and so that a dose of diclofenac sodium per administration is 70 mg to 150 mg.
Dependencies are inferred from the claim text.